211 related articles for article (PubMed ID: 23750283)
1. Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer.
Ma J; Xue Y; Liu W; Yue C; Bi F; Xu J; Zhang J; Li Y; Zhong C; Chen Y
PLoS One; 2013; 8(6):e66275. PubMed ID: 23750283
[TBL] [Abstract][Full Text] [Related]
2. Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1alpha activation.
Xue Y; Bi F; Zhang X; Zhang S; Pan Y; Liu N; Shi Y; Yao X; Zheng Y; Fan D
Int J Cancer; 2006 Jun; 118(12):2965-72. PubMed ID: 16395716
[TBL] [Abstract][Full Text] [Related]
3. Ras homolog gene family, member A promotes p53 degradation and vascular endothelial growth factor-dependent angiogenesis through an interaction with murine double minute 2 under hypoxic conditions.
Ma J; Xue Y; Cui W; Li Y; Zhao Q; Ye W; Zheng J; Cheng Y; Ma Y; Li S; Han T; Miao L; Yao L; Zhang J; Liu W
Cancer; 2012 Sep; 118(17):4105-16. PubMed ID: 22907703
[TBL] [Abstract][Full Text] [Related]
4. RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells.
El Atat O; Fakih A; El-Sibai M
Cells; 2019 Feb; 8(2):. PubMed ID: 30781697
[TBL] [Abstract][Full Text] [Related]
5. Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts.
Appledorn DM; Dao KH; O'Reilly S; Maher VM; McCormick JJ
BMC Cancer; 2010 Jan; 10():13. PubMed ID: 20067638
[TBL] [Abstract][Full Text] [Related]
6. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3'-kinase signaling pathway is essential for Rac1-induced hypoxia-inducible factor-1(alpha) and vascular endothelial growth factor expression.
Xue Y; Li NL; Yang JY; Chen Y; Yang LL; Liu WC
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2169-76. PubMed ID: 21357506
[TBL] [Abstract][Full Text] [Related]
8. Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production.
Yu X; Li W; Deng Q; You S; Liu H; Peng S; Liu X; Lu J; Luo X; Yang L; Tang M; Weng X; Yi W; Liu W; Wu S; Ding Z; Feng T; Zhou J; Fan J; Bode AM; Dong Z; Liu J; Cao Y
Mol Carcinog; 2017 May; 56(5):1414-1426. PubMed ID: 27996164
[TBL] [Abstract][Full Text] [Related]
9. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.
Banerjee A; Wu ZS; Qian PX; Kang J; Liu DX; Zhu T; Lobie PE
PLoS One; 2012; 7(11):e50098. PubMed ID: 23185544
[TBL] [Abstract][Full Text] [Related]
10. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway.
Wang Z; Wang N; Han S; Wang D; Mo S; Yu L; Huang H; Tsui K; Shen J; Chen J
PLoS One; 2013; 8(7):e68566. PubMed ID: 23861918
[TBL] [Abstract][Full Text] [Related]
11. c-Jun kinase mediates expression of VEGF induced at transcriptional level by Rac1 and Cdc42Hs but not by RhoA.
Saníger ML; Oya R; Macías D; Domínguez JN; Aránega A; Luque F
J Cell Biochem; 2006 Jun; 98(3):650-60. PubMed ID: 16440308
[TBL] [Abstract][Full Text] [Related]
12. Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression.
Márquez-Garbán DC; Gorrín-Rivas M; Chen HW; Sterling C; Elashoff D; Hamilton N; Pietras RJ
Cancer Lett; 2019 May; 449():66-75. PubMed ID: 30771431
[TBL] [Abstract][Full Text] [Related]
13. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
14. Zinc oxide nanoparticles-induced intercellular adhesion molecule 1 expression requires Rac1/Cdc42, mixed lineage kinase 3, and c-Jun N-terminal kinase activation in endothelial cells.
Li CH; Liao PL; Shyu MK; Liu CW; Kao CC; Huang SH; Cheng YW; Kang JJ
Toxicol Sci; 2012 Mar; 126(1):162-72. PubMed ID: 22166487
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42.
Wang R; Zhao N; Li S; Fang JH; Chen MX; Yang J; Jia WH; Yuan Y; Zhuang SM
Hepatology; 2013 Aug; 58(2):642-53. PubMed ID: 23468064
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
17. The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4.
Su M; Huang J; Liu S; Xiao Y; Qin X; Liu J; Pi C; Luo T; Li J; Chen X; Luo Z
Sci Rep; 2016 Jun; 6():28139. PubMed ID: 27338725
[TBL] [Abstract][Full Text] [Related]
18. Cdc42-mediated inhibition of GSK-3β improves angio-architecture and lumen formation during VEGF-driven pathological angiogenesis.
Hoang MV; Nagy JA; Senger DR
Microvasc Res; 2011 Jan; 81(1):34-43. PubMed ID: 20849862
[TBL] [Abstract][Full Text] [Related]
19. Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis.
Khan S; Shukla S; Farhan M; Sinha S; Lakra AD; Penta D; Kannan A; Meeran SM
Life Sci; 2020 Sep; 256():117976. PubMed ID: 32561397
[TBL] [Abstract][Full Text] [Related]
20. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
Jiang L; Luan Y; Miao X; Sun C; Li K; Huang Z; Xu D; Zhang M; Kong F; Li N
Br J Cancer; 2017 Aug; 117(5):695-703. PubMed ID: 28697175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
